You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Diabetes Articles
Popular Diabetes Articles
Highly Recommended Diabetes Articles
Send a link to this page to your friends and colleagues.
A study commissioned by healthcare company Novo Nordisk has reported that the cost of diabetes and pre-diabetes to the U.S. economy in 2007 was $218 billion. The study, conducted by The Lewin Group, projected that by 2034, the two conditions will cost the economy $336 billion per year.
The study looked at not only direct medical costs, such as medicines, monitoring and dosing equipment, and visits to doctors, clinics, and hospitals, but also indirect costs created by absenteeism and losses in productivity related to diabetes. It estimated direct costs at $153 billion, while indirect costs were $65 billion.
The $218 billion figure, said a spokesman for The Lewin Group, amounts to a $700 "hidden tax" on every person living in the United States.
The study further broke down diabetes and pre-diabetes costs in 2007 by categories of the disease:
One telling statistic was the breakdown in cost-per-year per patient:
The study concluded that the best public health policy would be to focus on high-risk patients who have not yet acquired the disease and encourage them to adopt the lifestyle changes that reduce the risk of developing diabetes. In one study, the Diabetes Prevention Program, those changes, which include moderate weight loss and increased physical activity, reduced the risk of diabetes by as much as 58 percent.
Novo Nordisk commissioned the study through its National Changing Diabetes® Program (NCDP).
* * *
Source: PRNewswire press release
1 comment - Feb 3, 2010
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.